Mankind Pharma Limited has informed the Exchange regarding Board meeting held on February 03, 2026.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has informed the stock exchange about a board meeting held on February 3, 2026. This is a standard compliance filing required under SEBI listing regulations, where companies notify the exchange whenever the board convenes. The filing itself does not disclose any specific decisions, financial results, or actions taken during the meeting. Investors would typically need to refer to a separate filing for the actual outcomes or resolutions passed at the meeting.
Minimal direct impact on the stock price from this intimation alone. Shareholders should look out for the detailed outcome of the board meeting, which is usually filed separately and may contain material information such as results, dividends, or strategic decisions.